Renal Cell Carcinoma
📧 Sign up to get email alerts when something new happens for Renal Cell Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2014-01-30Clinical Trial Update: Seneca Valley Virus-001 and Cyclophosphamide in Treating Young Patients With Relapsed or Refractory Neuroblastoma, Rhabdomyosarcoma, or Rare Tumors With Neuroendocrine Features [Phase 1]
Phase 1 clinical trial update for Seneca Valley Virus-001 with Cyclophosphamide in pediatric patients with relapsed/refractory neuroblastoma…
-
CLINICAL_TRIALS trial_result · 2014-01-28Clinical Trial Update: A Phase 1b Study of SGN-75 in Combination With Everolimus in Patients With Renal Cell Carcinoma [Phase 1]
This is a Phase 1b study evaluating SGN-75 in combination with everolimus for renal cell carcinoma, which has been terminated.
-
CLINICAL_TRIALS trial_result · 2014-01-27Clinical Trial Update: Erlotinib in Treating Patients With Advanced Kidney Cancer [Phase 2]
Phase 2 clinical trial evaluating Erlotinib in advanced renal cell carcinoma has completed, with results posted in 2014.
-
CLINICAL_TRIALS trial_result · 2014-01-14Clinical Trial Update: Neoadjuvant Clinical Trial to Evaluate the Efficacy of Bevacizumab for Renal Cell Carcinoma [Phase 2]
Phase 2 neoadjuvant trial evaluating bevacizumab for renal cell carcinoma has completed with results posted in 2014.
-
CLINICAL_TRIALS trial_result · 2014-01-14Clinical Trial Update: Correlation of the Clinical Behaviour of Renal Cell Carcinoma (RCC) After Debulking Nephrectomy With Tumor Gene Expression in Nephrectomy Specimens
This completed clinical trial examined whether the clinical behavior of renal cell carcinoma after debulking nephrectomy correlates with tum…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2014-01-14Clinical Trial Update: Bevacizumab With or Without MEDI-522 in Treating Patients With Unresectable or Metastatic Kidney Cancer [Phase 1, Phase 2]
This clinical trial update reports the termination of a Phase 1/2 study evaluating bevacizumab with or without MEDI-522 in patients with unr…
-
CLINICAL_TRIALS trial_result · 2014-01-09Clinical Trial Update: Interleukin-2 in Treating Patients With Metastatic Kidney Cancer [Phase 4]
This is a completed Phase 4 clinical trial update evaluating interleukin-2 in patients with metastatic renal cell carcinoma (kidney cancer).
-
CLINICAL_TRIALS trial_result · 2014-01-07Clinical Trial Update: Sunitinib in Treating Patients With Kidney Cancer That Cannot Be Removed by Surgery [Phase 2]
Phase 2 trial update showing results for sunitinib in unresectable kidney cancer (renal cell carcinoma); results were posted in 2014.
-
CLINICAL_TRIALS trial_result · 2014-01-06Clinical Trial Update: Irradiated Donor Lymphocytes in Treating Patients With Metastatic Kidney Cancer [Phase 2]
A Phase 2 clinical trial evaluating irradiated donor lymphocytes for metastatic renal cell carcinoma has terminated with results posted in 2…
-
CLINICAL_TRIALS trial_result · 2014-01-06Clinical Trial Update: UCN-01 in Treating Patients With Advanced or Metastatic Kidney Cancer [Phase 2]
Phase 2 clinical trial update of UCN-01 in patients with advanced or metastatic renal cell carcinoma (kidney cancer) sponsored by UCSF.
-
CLINICAL_TRIALS trial_result · 2013-12-20Clinical Trial Update: Non-Interventional Study Of Indian Patients With Advanced Renal Cell Cancer Receiving Therapy With Sutent
Pfizer sponsored a non-interventional study in Indian patients with advanced renal cell carcinoma treated with Sutent (sunitinib). The study…
-
CLINICAL_TRIALS trial_result · 2013-12-19Clinical Trial Update: Interferon Alfa With or Without Interleukin-2 and Fluorouracil in Treating Patients With Advanced Metastatic Kidney Cancer [Phase 3]
Phase 3 trial update evaluating interferon alfa with or without interleukin-2 and fluorouracil in advanced/metastatic kidney cancer. The stu…
-
CLINICAL_TRIALS trial_result · 2013-12-19Clinical Trial Update: Vaccine Therapy With or Without Fludarabine in Treating Patients With Stage IV Kidney Cancer [Phase 2]
Clinical trial update on a phase 2 study of vaccine therapy with or without fludarabine in stage IV renal cell carcinoma.
-
CLINICAL_TRIALS trial_result · 2013-12-04Clinical Trial Update: Interleukin-2, Vinblastine, and GM-CSF in Treating Patients With Metastatic Kidney Cancer [Phase 2]
A Phase 2 trial evaluates a combination of interleukin-2, vinblastine, and GM-CSF for metastatic renal cell carcinoma; the current trial sta…
-
CLINICAL_TRIALS trial_result · 2013-12-03Clinical Trial Update: Extension Study to VEG105192 to Assess Pazopanib in Patients With Advanced/Metastatic Renal Cell Cancer [Phase 3]
An extension study of pazopanib (VEG105192) in patients with advanced or metastatic renal cell carcinoma has completed Phase 3 and posted re…
-
CLINICAL_TRIALS trial_result · 2013-11-20Clinical Trial Update: AZD2171 in Treating Patients With Refractory Metastatic Kidney Cancer [Phase 2]
Phase 2 trial of cediranib (AZD2171) in patients with refractory metastatic kidney cancer was terminated, with results posted in 2013.
-
CLINICAL_TRIALS trial_result · 2013-11-14Clinical Trial Update: Community Oncology Setting Disease Outcomes of Sorafenib (Nexavar) Use in Advanced Renal Cell Carcinoma
The study reports disease outcomes for sorafenib in patients with advanced renal cell carcinoma treated in community oncology settings.
-
CLINICAL_TRIALS trial_result · 2013-11-06Clinical Trial Update: Interleukin-2 in Treating Patients With Stage III or Stage IV Kidney Cancer That Has Been Removed With Surgery [Phase 2]
Phase 2 clinical trial update evaluating interleukin-2 for patients with stage III or stage IV renal cell carcinoma after surgical removal o…
-
CLINICAL_TRIALS trial_result · 2013-10-11Clinical Trial Update: Research Study for Patients With Metastatic Renal Cell Carcinoma [Phase 2]
A Phase 2 clinical trial for metastatic renal cell carcinoma sponsored by Bayer has been terminated.
-
CLINICAL_TRIALS trial_result · 2013-09-24Clinical Trial Update: Comparison of Immune Response Following Surgical Management of Renal Tumors
The Emory University–sponsored trial evaluating immune response after surgical management of renal tumors has been terminated.
-
CLINICAL_TRIALS trial_result · 2013-09-19Clinical Trial Update: A Drug-Drug Interaction Study of the Effects of XL184 (Cabozantinib) on Rosiglitazone in Subjects With Solid Tumors [Phase 1]
Phase 1 study evaluating the drug-drug interaction between cabozantinib (XL184) and rosiglitazone in subjects with solid tumors; the trial h…
-
CLINICAL_TRIALS trial_result · 2013-09-05Clinical Trial Update: PS-341 in Treating Patients With Metastatic Kidney Cancer [Phase 2]
A Phase 2 study evaluating PS-341 (bortezomib) in patients with metastatic kidney cancer has completed.
-
CLINICAL_TRIALS trial_result · 2013-09-05Clinical Trial Update: Trial of G250 Peptide and IL-2 Following Surgical Resection of Locally Advanced/Metastatic Renal Cell Carcinoma [Phase 2]
A Phase 2 trial evaluating G250 peptide plus interleukin-2 after surgical resection of locally advanced or metastatic renal cell carcinoma w…
-
CLINICAL_TRIALS trial_result · 2013-08-30Clinical Trial Update: Vorinostat in Treating Patients With Kidney Cancer [Phase 2]
This document reports the results of a Phase 2 clinical trial of Vorinostat in patients with recurrent or stage IV renal cell carcinoma. Res…
-
CLINICAL_TRIALS trial_result · 2013-08-26Clinical Trial Update: Oblimersen and Interferon Alfa in Treating Patients With Metastatic Renal Cell Cancer [Phase 2]
Phase 2 trial evaluating oblimersen in combination with interferon alfa for metastatic renal cell carcinoma has completed.